Setondji Cocou Modeste Alexandre Yahouedehou
Overview
Explore the profile of Setondji Cocou Modeste Alexandre Yahouedehou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albuquerque C, Yahouedehou S, Francisco M, Fraiji N, de Siqueira I, Goncalves M
Braz J Infect Dis
. 2024 Apr;
28(2):103741.
PMID: 38670165
Sickle Cell Disease (SCD) is a hereditary disease characterized by extravascular and intravascular hemolysis and clinical variability, from mild pain to potentially life-threatening. Arboviruses include mainly Zika (ZIKV), Chikungunya (CHKV),...
2.
Dos Santos Neres J, Yahouedehou S, Goncalves M
Pharmaceuticals (Basel)
. 2023 Jun;
16(6).
PMID: 37375804
Inconsistent therapeutic responses have been observed among patients with sickle cell anemia (SCA) undergoing hydroxyurea (HU) following the adoption of the standardized protocol. Moreover, this treatment regimen necessitates a prolonged...
3.
Martins G, Nonaka C, Rossi E, de Lima A, Adanho C, Oliveira M, et al.
Cells
. 2023 May;
12(8).
PMID: 37190030
Background: Sickle cell disease (SCD) is a highly prevalent genetic disease caused by a point mutation in the gene, which can lead to chronic hemolytic anemia and vaso-occlusive events. Patient-derived...
4.
Menezes J, Carvalho M, Rocha L, Dos Santos F, Adorno E, de Souza C, et al.
Sci Rep
. 2023 May;
13(1):7215.
PMID: 37137941
Sickle cell disease (SCD) patients often exhibit a dyslipidemic sub-phenotype. Paraoxonase 1 (PON 1) is a serum glycoprotein associated with the high-density lipoproteins cholesterol (HDL-C), and variability in PON1 activity...
5.
Santos E, Santana P, Silva de Jesus L, Melo G, Yahouedehou S, da Guarda C, et al.
Hematol Rep
. 2023 Feb;
15(1):119-129.
PMID: 36810556
Sickle cell disease (SCD) is characterized by the presence of the variant S hemoglobin (HbS). The homozygous genotype (HbSS) is sickle cell anemia (SCA), while the double heterozygous of HbS...
6.
Adanho C, Yahouedehou S, Santana S, Vieira C, Santiago R, de Santana J, et al.
Front Pediatr
. 2022 Sep;
10:914466.
PMID: 36090571
Background: Stroke is one of the highest complications of sickle-cell anemia (SCA). The Transcranial Doppler (TCD) has been adopted worldwide as a gold standard method for detecting alterations in the...
7.
Santos E, Melo G, Santana P, Quadros I, Yahouedehou S, da Guarda C, et al.
Biomolecules
. 2022 Feb;
12(2).
PMID: 35204817
Sickle leg ulcers (SLU) are malleoli lesions with exuberant hemolytic pathophysiology. The microRNAs are potential genetic biomarkers for several pathologies. Thereby, we aimed to assess the expression of circulating miR-199a-5p,...
8.
Inclusion Complexes of Non-Steroidal Anti-Inflammatory Drugs with Cyclodextrins: A Systematic Review
Miranda G, Santos V, Bessa J, Teles Y, Yahouedehou S, Goncalves M, et al.
Biomolecules
. 2021 Mar;
11(3).
PMID: 33673414
Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most widely used classes of medicines in the treatment of inflammation, fever, and pain. However, evidence has demonstrated that these drugs can...
9.
Figueiredo C, Santiago R, da Guarda C, Oliveira R, Fiuza L, Yahouedehou S, et al.
PLoS One
. 2021 Feb;
16(2):e0246067.
PMID: 33539452
Priapism is a urologic emergency characterized by an uncontrolled, persistent and painful erection in the absence of sexual stimulation, which can lead to penile fibrosis and impotence. It is highly...
10.
Santiago R, Figueiredo C, Fiuza L, Yahouedehou S, Oliveira R, Aleluia M, et al.
Dis Markers
. 2020 Oct;
2020:8867986.
PMID: 33062074
Individuals with sickle cell anemia (SCA) present chronic anemia, hemolysis, an exacerbated inflammatory response, and heterogeneous clinical complications, which may be modulated by the transforming growth factor beta (TGF-) pathway....